PlainRecalls

Pacira Pharmaceuticals INC

Compiled from official public sources by the publisher.

4 recalls on record · Latest: Jul 3, 2024

Subscribe to new Pacira Pharmaceuticals INC recalls (RSS)

Agency notice ledger

Federal filing book Pacira Pharmaceuticals INC LIGHT-BOOK · SINGLE-AGENCY

#3,108 of 14,151 · 4 notices · 0.004% archive

  • BOOK 4 notices
  • RANK #3,108 of 14,151
  • SHARE 0.004% archive
  • AGENCY FDA Drug (4)
  • CAT drugs
  • CATS 1 category
  • LATEST Jul 3, 2024
  • PHOTO 1 Epic, LLC

Nearest notice-volume peer: 1 Epic, LLC (0 notice gap)

Pacira Pharmaceuticals INC accounts for about 0.004% of the 104,423-notice archive on 4 distinct filings — a light share signal beside absolute volume. FDA · CPSC · USDA FSIS · NHTSA notice stamps for this firm. Read with this firm → · Dominant category → · Similar-volume firm →

How Pacira Pharmaceuticals INC compares to 14,151 recalling firms

Pacira Pharmaceuticals INC ranks 3,108th of 14,151 tracked firms by distinct recall-event count. Archive size reflects filing volume, not inherent product danger.

Pacira Pharmaceuticals INC vs all firms by recall-notice count

Where this firm's archive sits among every tracked recalling manufacturer

4 3108th of 14151 higher than 10,859 of 14,151 firms

Firms, banded by distinct federal recall-event inventory

Each bar is a band; taller bars hold more firms. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source FDA · CPSC · USDA FSIS · NHTSA federal recall filings · 2026-09-13

Pacira Pharmaceuticals INC in the notice-volume neighbourhood

Distinct federal recall events among this firm and nearest nationwide peers

notices

What this shows Pacira Pharmaceuticals INC holds about 0.004% of archive notices alongside 4 distinct filings.

Source FDA · CPSC · USDA FSIS · NHTSA filings aggregated by PlainRecalls As of September 2026
FDA Drug Moderate Jul 3, 2024

Zilretta (triamcinolone acetonide extended-release injectable suspension), 32 mg per vial, Rx only, Manufactured for: Pacira Pharmaceuticals Inc., San Diego, CA 92121, NDC 65250-003-01 (carton) NDC 65250-001-01 (vial) with Diluent 5 mL Sterile single-use vial, Rx Only, Mfd. for: Pacira Pharmaceuticals, Inc. NDC 65250-002-01
FDA Drug Moderate Jun 19, 2024

Drug Vial Label: Zilretta¿ (triamcinolone acetonide extended-release injectable suspension), 32 mg per vial, Rx only, Manufactured for: Pacira Pharmaceuticals Inc., San Diego, CA 92121, NDC 65250-001-01. Diluent Vial Label: Diluent, 5mL, Sterile single use, Rx only, Manufactured for Pacira Pharmaceuticals Inc., NDC 65250-002-01. Carton Label: Drug Vial Label: Zilretta¿ (triamcinolone acetonide extended-release injectable suspension), 32 mg per vial, Rx only, Manufactured for: Pacira Pharmaceut
FDA Drug Moderate Dec 11, 2019

EXPAREL, Bupivicaine Liposome Injectable Suspension, 1.3%, 266 mg/20 mL (13 mg/mL), Sterile, 20 mL vial, Rx only, Manufactured by: Pacira Pharmaceuticals, Inc. San Diego, CA 92121. NDC: 65250-266-20,
FDA Drug Moderate Mar 6, 2013

EXPAREL (bupivacaine liposome injectable suspension), 1.3%, 266 mg/20 mL (13.3 mg/mL) single use vials, INVESTIGATIONAL USE. For Infiltration Only. Not for any other route of administration. Manufactured by Paelra Pharmaceuticals. Inc., San Diego, California, USA

Pacira Pharmaceuticals INC is a small archive contributor

Drug and device firms outside this manufacturer and state, matched by notice volume and category footprint.

Similar recall count

Nearest multi-notice firms by distinct-event totals (4 here).

1 Epic, LLC 4 3rd Day Beverages LLC 4 A.p. Deauville, LLC 4 Aaa Pharmaceutical, Inc. 4 Aap Implantate Ag 4

Similar drugs volume

Nearest multi-notice firms in the same narrow category lane.

Aaa Pharmaceutical, Inc. 4 Advanced Accelerator Applications USA, Inc. 4 Alkermes Inc 4 Allergan 4

Frequently Asked Questions

How many federal recall notices name Pacira Pharmaceuticals INC? ▼
PlainRecalls indexes 4 distinct federal recall events naming Pacira Pharmaceuticals INC, aggregated from FDA, CPSC, USDA FSIS, and NHTSA filings (archive as of September 2026). That count is an issuance inventory, not a hazard score.
Where does Pacira Pharmaceuticals INC sit among other recalling firms? ▼
Pacira Pharmaceuticals INC ranks #3,108 of 14,151 by distinct recall-event count among 14,151 firms in this archive (77th percentile of firms with fewer notices). Rank tracks filing frequency, not product danger.
Which agency issues most of Pacira Pharmaceuticals INC's notices? ▼
FDA Drug accounts for 4 of this firm's 4 indexed notices.
What product category dominates Pacira Pharmaceuticals INC's filing book? ▼
Filings for Pacira Pharmaceuticals INC span 1 product category, led by drugs. Browse that category archive for peer firms and related notices.
Is a higher notice count more dangerous? ▼
No. Archive size reflects how often federal agencies publish recalls naming the firm — reporting volume, coverage, and product range all move the number. Always verify the individual notice with the issuing agency before acting on a specific product.
Pacira Pharmaceuticals INC: 4 federal recall notices aggregated from FDA, CPSC, USDA FSIS, and NHTSA filings (lead agency FDA Drug). Verify individual notices with FDA directly before acting on a specific recall.

Firm-level totals aggregate distinct federal recall events naming Pacira Pharmaceuticals INC; individual notices remain authoritative on each linked recall page.

Methodology · Corrections · FDA · CPSC · USDA FSIS · NHTSA · Archive as of September 2026